Orakl Oncology raised €3.0M in a funding round in Oct 2023. The company is based in Villejuif, France. Investors in the round: HCVC, Speedinvest, Verve Ventures. Data as of 23 Sept 2026.
Reported in EUR — no conversion. €3.0M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
